You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives USFDA final approval for Atenolol and Chlorthalidone Tablets

Capital Market 

has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (US RLD Tenoretic), 50 mg/25 mg and 100 mg/25 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

This medication is used to treat (hypertension). Lowering helps prevent strokes, and kidney problems.

Atenolol belongs to a class of known as It works by blocking the action of certain in your body, such as epinephrine on the heart and blood vessels. This effect lowers the heart rate, blood pressure and strain on the heart. Chlorthalidone is a 'water pill (diuretic) and causes the body to get rid of extra salt and water. It also helps to relax the blood vessels so that blood can flow easily.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, March 12 2019. 12:33 IST